Wednesday, 16 January 2019

Vaccines News

  • WHO and World Food Program join forces to reach zero Ebola cases

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2015

    Singapore: WHO and United Nations World Food Program (WFP) have come together to build logistics strength for Ebola-affected countries of Guinea, Liberia and Sierra Leone to help get the cu...Read more

  • FDA nod for Sanofi quadrivalent flu vaccine

    Vaccines |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

    Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza vaccine, Fluzone Quadrivalent, which is the newest addition...Read more

  • Vaccine for AIDS in ten years: Bill Gates

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2015

    Singapore: With no cure or vaccine available for AIDS, that is spreading across the globe like a wide epidemic, billionaire philanthropist Mr Bill Gates, who spends millions of dollars on A...Read more

  • AIDS 2014: Slash in fund jolts HIV research

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2014

    Singapore: Investment in HIV prevention research has declined posing a challenge to the pipeline of HIV prevention products in various stages of development and implementation of an effecti...Read more

  • Novartis completes divestiture of influenza vaccines business

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 18 Aug, 2015

    Singapore: Novartis has announced that it has completed the divestiture of its influenza vaccine unit to CSL Limited. This marks the end of a series of transactions previously announced and...Read more

  • J&J's HIV vaccine to begin human trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2015

    Singapore: Bringing new hope to millions of people worldwide, the experimental HIV vaccine developed by Johnson & Johnson has shown promise in early clinical trials. As per reports the ...Read more

  • Agilent, A*Star, French univ sign biologics MoU

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2013

    Singapore: Agilent Technologies, Glyco-MEV laboratory at the University of Rouen, France, and Bioprocessing Technology Institute (BTI) at the Agency for Science, Technology and Research (A*...Read more

  • Stanford Univ reverse vaccine to treat diabetes

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

    Singapore: Scientists at Stanford University, US, and Leiden University Medical Center in the Netherlands, have tested a 'reverse vaccine' that dampens the immune systems of people with typ...Read more

  • EU approves Merck's Keytruda for melanoma

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2015

    Merck has announced that the European Commission has approved KEYTRUDA (pembrolizumab), its anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma in adults...Read more

  • Astellas, ClearPath to enter strategic partnership

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2014

    Singapore: Astellas Pharma and ClearPath Development Company have announced a strategic partnership to form a portfolio of development companies focused on vaccines targeting infectious dis...Read more

  • Sanofi gears up to introduce dengue vaccine

    Vaccines |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2014

    Healthcare stakeholders are keeping high hopes with the successful results of Sanofi Pasteur's Phase III trial of dengue vaccine completed this year and a vaccine may be available soon. The...Read more

  • India's vaccine future looks bright despite hurdles

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    The Indian vaccine industry has been in the past few years following close on the footsteps of the Indian pharma sector. The vaccine industry has been making concerted efforts to develop va...Read more

  • HIV vaccine dream can now be a reality

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

    Singapore: Scientists at Vaccine and Gene Therapy Institute of Florida (VGTI), US, a nonprofit immunological research institute, showed that previously unidentified dysfunction in follicula...Read more

  • Imaxio starts human trials with re-engineered TB antigen

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

    Singapore: Vaccine firm Imaxio's proprietary pro-immunogenic technology, IMX313, has been administered for the first time in humans in a tuberculosis vaccine phase I clinical study. The tri...Read more

  • A push to accelerate next-gen immunogen design

    Vaccines |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2012

    According to the International AIDS Vaccine Initiative (IAVI), in September 2009, scientists reported isolation of a pair of potent and broadly neutralizing antibodies against HIV. That dis...Read more

  • World Immunization Week: WHO urges renewed efforts

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 25 Apr, 2015

    Singapore: Dr Poonam Khetrapal Singh, regional director, WHO South-East Asia, in her message has called for ensuring equity with the lifesaving drugs. "Every year vaccination averts 2 to 3 ...Read more

  • Thai HIV vaccine shows promise in clinical trials

    Vaccines |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2014

    Singapore: The Thai HIV vaccine that showed promise in initial clinical trials held in Thailand in 2009, has also exhibited significant protection in a clinical trial held in South Africa. ...Read more

  • Painless vaccination unveiled!

    Vaccines |  Influencers | By Aishwarya Venkatesh  | 0 Comment | 01 May, 2015

    Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is not widely accepted by all sections of the society. Vaccination can be...Read more

Survey Box

Are Healthcare institutions in Asia reporting business improvements after adopting digital tools?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls